Caribou Biosciences CRBU
NASDAQ CRBU
$0.54 -0.02 (-3.93%)
As of: Oct 23, 2026 · 2:34 PM EDT

Caribou Biosciences (CRBU) Non Operating Interest Expenses (2020 - 2021)

Updated

Caribou Biosciences (CRBU) reported Non Operating Interest Expenses of $8,000 for FY2021, down 60.0% from $20,000 in FY2020.

Analysis

Caribou Biosciences (CRBU) Non Operating Interest Expenses (2020 - 2021) Analysis & Trends

  • According to Business Quant data, Non Operating Interest Expenses came in at $20,000 in FY2020 (+400.0%) and $4,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,128.85 Bn 1,097.43 Bn 19.71 Bn -
2 Johnson & Johnson 634.21 Bn 554.07 Bn 17.30 Bn 217.00 Mn
3 AbbVie 505.78 Bn 478.89 Bn 12.70 Bn -
4 Merck 357.64 Bn 312.02 Bn 12.21 Bn -
5 Novartis Ag 290.31 Bn 254.30 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 265.38 Bn 239.06 Bn 12.86 Bn 435.00 Mn
7 Amgen 238.11 Bn 193.51 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn 247.00 Mn
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn -
10 Caribou Biosciences 54.16 Mn -462.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 2,000.00
Dec 31, 2020 6,000.00
Sep 30, 2020 6,000.00
Jun 30, 2020 5,000.00
API Access

Caribou Biosciences Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CRBU&period=max&api_key=YOUR_API_KEY